Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 1 2 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 60 Prostatic Neoplasms 52 Squamous Cell Carcinoma of Head and Neck 43 Carcinoma, Non-Small-Cell Lung 39 Head and Neck Neoplasms 37 Lung Neoplasms 35 Lymphoma 34 Leukemia 22 Brain Neoplasms 20 Central Nervous System Neoplasms 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Glioblastoma 18 Uterine Cervical Neoplasms 17 Sarcoma 17 Rectal Neoplasms 17 Lymphoma, Follicular 16 Esophageal Squamous Cell Carcinoma 16 Esophageal Neoplasms 15 Lymphoma, Large B-Cell, Diffuse 14 Hodgkin Disease 14 Burkitt Lymphoma 14 Adenocarcinoma of Lung 13 Oligodendroglioma 12 Lymphoma, Non-Hodgkin 12 Neoplasm Metastasis 11 Astrocytoma 11 Rhabdomyosarcoma 10 Lymphoma, Large-Cell, Immunoblastic 10 Neuroblastoma 9 Nasopharyngeal Carcinoma 9

Interventions

Rituximab 14 pirtobrutinib 6 ibrutinib 4 Vincristine 4 Doxorubicin 4 Prednisone 3 Cytarabine 3 Cyclophosphamide 3 zanubrutinib 2 acalabrutinib 2 Methotrexate 2 Etoposide 2 Bendamustine Hydrochloride 2 venetoclax 1 tositumomab I-131 1 idelalisib 1 ibritumomab tiuxetan 1 etoposide phosphate 1 entecavir 1 cirmtuzumab 1 axicabtagene ciloleucel 1 VAP-cyclo protocol 1 Tenofovir 1 Radiotherapy 1 Melphalan 1 Ifosfamide 1 Gemcitabine 1 Everolimus 1 Drug Therapy 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, B-Cell × Radiotherapy × Clear all

NCT00841945 2017-02-23

Treatment of Aggressive Localized Lymphoma

French Innovative Leukemia Organisation

Phase 3 Terminated

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡